Company Overview of ProteoSys AG
ProteoSys AG provides solutions for the drug development process focusing on target system discovery, target validation, modes of action, studies of side effects, and toxicology. The company develops a combination of proprietary software developments and existing tools and programs for data analysis and data mining. ProteoSys was founded in 2000 and is based in Mainz, Germany.
Founded in 2000
49 61 31501920
49 61 315019211
Key Executives for ProteoSys AG
Similar Private Companies By Industry
|2e Systems GmbH||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|John F. Kennedy Center For The Performing Arts||United States|
|NYC2012, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact ProteoSys AG, please visit www.proteosys.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.